Price $1.34 |
Market Cap
66.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
2.3
|
P/B
0.97
|
P/S
0.66
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
13.4
|
Op. Cash Flow
10.2K
|
FCF
0.1
|
|
Op. Margin
45.40%
|
Net Margin
32.70%
|
ROE
212.30%
|
ROI
-166.80%
|
|
ROA
41.70%
|
EPS Growth
158.20%
|
Current Ratio
4.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
